Reuters logo
BRIEF-Orexigen Therapeutics Q3 loss per share $1.35
November 13, 2017 / 9:06 PM / 7 days ago

BRIEF-Orexigen Therapeutics Q3 loss per share $1.35

Nov 13 (Reuters) - Orexigen Therapeutics Inc

* Orexigen Therapeutics announces third quarter 2017 financial results

* Q3 loss per share $1.35

* Q3 revenue $18.9 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below